Catalio Capital Management, LP Bridge Bio Pharma, Inc. Transaction History
Catalio Capital Management, LP
- $411 Billion
- Q1 2025
A detailed history of Catalio Capital Management, LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Catalio Capital Management, LP holds 962,883 shares of BBIO stock, worth $31.6 Million. This represents 8.1% of its overall portfolio holdings.
Number of Shares
962,883
Previous 898,458
7.17%
Holding current value
$31.6 Million
Previous $24.7 Billion
35.02%
% of portfolio
8.1%
Previous 5.39%
Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
361Shares Held
185MCall Options Held
12.8MPut Options Held
2.09M-
Viking Global Investors LP22.1MShares$724 Million2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$633 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$489 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$409 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$236 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.87B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...